1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational...
-
Upload
martha-murphy -
Category
Documents
-
view
215 -
download
0
Transcript of 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational...
![Page 1: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/1.jpg)
1
Dose-Response Modeling: Past, Present, and Future
Rory B. Conolly, Sc.D.Center for Computational Systems Biology
& Human Health AssessmentCIIT Centers for Health Research
(919) 558-1330 - [email protected] - e-mail
SOT Risk Assessment Specialty Section, Wednesday, December 15, 2004
![Page 2: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/2.jpg)
2
Outline
• Why do we care about dose response?
• Historical perspective– Brief, incomplete!
• Formaldehyde
• Future directions
![Page 3: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/3.jpg)
3
Perspective
• This talk mostly deals with issues of cancer risk assessment, but I see no reason for any formal separation of the methodologies for cancer and non cancer dose-response assessments– PK
– Modes of action
– Tumors, reproductive failure, organ tox, etc.
![Page 4: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/4.jpg)
4
Typical high dose rodent data – what do they tell us?
Res
pons
e
Dose
![Page 5: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/5.jpg)
5
Not much!R
espo
nse
Dose
Interspecies
![Page 6: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/6.jpg)
6
PossibilitiesR
espo
nse
Dose
Interspecies
![Page 7: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/7.jpg)
7
PossibilitiesR
espo
nse
Dose
Interspecies
![Page 8: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/8.jpg)
8
PossibilitiesR
espo
nse
Dose
Interspecies
![Page 9: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/9.jpg)
9
PossibilitiesR
espo
nse
Dose
Interspecies
![Page 10: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/10.jpg)
10
Benzene Decision of 1980
• U.S. Supreme Court says that exposure standards must be accompanied by a demonstration of “significant risk”– Impetus for modeling low-dose dose response
![Page 11: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/11.jpg)
11
1984 Styrene PBPK model(TAP, 73:159-175, 1984)
A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans
John C. Ramseya and Melvin E. Andersenb
a Toxicology Research Laboratory, Dow Chemical USA, Midland, Michigan 48640, USAb Biochemical Toxicology Branch, Air Force Aerospace Medical Research Laboratory (AFAMRL/THB), Wright-Patterson Air Force Base, Ohio 45433, USA
![Page 12: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/12.jpg)
12
Biologically motivated computational models(or)
Biologically based computational models
• Biology determines– The shape of the dose-response curve
– The qualitative and quantitative aspects of interspecies extrapolation
• Biological structure and associated behavior can be– described mathematically
– encoded in computer programs
– simulated
![Page 13: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/13.jpg)
13
Experiments to understandmechanisms of toxicity andextrapolation issues
Computationalmodels
Riskassessment
Biologically-based computational models: Natural bridges between research and risk
assessment
![Page 14: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/14.jpg)
14
Garbage in – garbage out
• Computational modeling and laboratory experiments must go hand-in-hand
![Page 15: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/15.jpg)
15
Refining the description with research on pharmacokinetics and pharmacodynamics
(mode of action)R
espo
nse
Dose
Interspecies
![Page 16: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/16.jpg)
16
Refining the description with research on pharmacokinetics and pharmacodynamics
(mode of action)R
espo
nse
Dose
Interspecies
![Page 17: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/17.jpg)
17
Refining the description with research on pharmacokinetics and pharmacodynamics
(mode of action)R
espo
nse
Dose
Interspecies
![Page 18: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/18.jpg)
18
Res
pons
e
Refining the description with research on pharmacokinetics and pharmacodynamics
(mode of action)
Dose
Interspecies
![Page 19: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/19.jpg)
19
Formaldehyde nasal cancer in rats:
A good example of extrapolations across doses and species
![Page 20: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/20.jpg)
20
![Page 21: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/21.jpg)
21
Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, Pavkov KL
Cancer Research, 40:3398-3402 (1980)
Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor.
1980 - First report of formaldehyde-induced tumors
![Page 22: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/22.jpg)
22
Formaldehyde bioassay results
0
10
20
30
40
50
60
T
um
or R
espo
nse
(%)
0 0.7 2 6 10 15
Exposure Concentration (ppm)
Kerns et al., 1983
Monticello et al., 1990
![Page 23: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/23.jpg)
23
Mechanistic Studies and Risk Assessments
![Page 24: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/24.jpg)
24
What did we know in the early ’80’s?
• Formaldehyde is a carcinogen in rats and mice
• Human exposures roughly a factor of 10 of exposure levels that are carcinogenic to rodents.
![Page 25: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/25.jpg)
25
1982 – Consumer Product Safety Commission (CPSC) voted to ban urea-formaldehyde foam insulation.
![Page 26: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/26.jpg)
26
Casanova-Schmitz M, Heck HD
Toxicol Appl Pharmacol 70:121-32 (1983)
Effects of formaldehyde exposure on the extractability of DNA from proteins in the rat nasal mucosa.
1983 - Formaldehyde cross-links DNA with proteins - “DPX”
![Page 27: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/27.jpg)
27
DPX
(FORMALDEHYDEIN AIR)
MUCUS
RESPIRATORYEPITHELIUM
CH2
CH2
CH2
![Page 28: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/28.jpg)
28
Starr TB, Buck RD
Fundam Appl Toxicol 4:740-53 (1984)
The importance of delivered dose in estimating low-dose cancer risk from inhalation exposure to formaldehyde.
1984 - Risk Assessment Implications
![Page 29: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/29.jpg)
29
1985 – No effect on blood levels
Heck, Hd’A, Casanova-Schmitz, M, Dodd, PD, Schachter, EN, Witek, TJ, and Tosun, T
Am. Ind. Hyg. Assoc. J. 46:1. (1985)
Formaldehyde (C2HO) concentrations in the blood of humans and Fisher-344 rats exposed to C2HO under controlled conditions.
![Page 30: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/30.jpg)
30
1987 – U.S. EPA cancer risk assessment
• Linearized multistage (LMS) model
– Low dose linear
– Dose input was inhaled ppm
– U.S. EPA declined to use DPX data
![Page 31: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/31.jpg)
31
Summary: 1980’s
• Research– DPX – delivered dose
– Breathing rate protects the mouse (Barrow)
– Blood levels unchanged
• Regulatory actions– CPSC ban
– US EPA risk assessment
![Page 32: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/32.jpg)
32
Key events during the ’90s
• Greater regulatory acceptance of mechanistic data for
risk assessment (U.S. EPA)
• Cell replication dose-response
• Better understanding of DPX (Casanova & Heck)
• Dose-response modeling of DPX (Conolly, Schlosser)
• Sophisticated nasal dosimetry modeling (Kimbell)
• Clonal growth models for cancer risk assessment
(Moolgavkar)
![Page 33: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/33.jpg)
33
1991 – US EPA cancer risk assessment
• Linearized multistage (LMS) model– Low dose linear
– DPX used as measure of dose
![Page 34: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/34.jpg)
34
Monticello TM, Miller FJ, Morgan KT
Toxicol Appl Pharmacol 111:409-21 (1991)
Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde.
1991, 1996 - regenerative cellular proliferation
![Page 35: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/35.jpg)
35
Normal respiratory epithelium in the rat nose
![Page 36: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/36.jpg)
36
Formaldehyde-exposed respiratory epitheliumin the rat nose (10+ ppm)
![Page 37: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/37.jpg)
37
Dose-response for cell division rate
2.00E-04
3.00E-04
4.00E-04
5.00E-04
6.00E-04
7.00E-04
0 1 2 3 4 5 6 7
ppm formaldehyde
(Raw data)
![Page 38: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/38.jpg)
38
DPX submodel – simulation of rhesus monkey data
1 2 3 4 5 6 710
-4
10-3
10-2
10-1
PPM
DPX (pmol/mm
3)
DPX dose-response for Rhesus monkey
Vmax: 91.02. pmol/mm3/min
Km: 6.69 pmol/mm3 kf: 1.0878 1/min Tissue thickness ALWS: 0.5401 mm MT: 0.3120 mm NP: 0.2719 mm
![Page 39: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/39.jpg)
39
Summary: Dose-response inputs to the clonal growth model
• Cell replication– J-shaped
• DPX– Low dose linear
![Page 40: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/40.jpg)
40
CFD Simulation of Nasal Airflow(Kimbell et. al)
![Page 41: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/41.jpg)
41
2-Stage clonal growth model(MVK model)
Normalcells (N)
Division
N)
Death/differentiation
(N)
Mutation(N )
Initiatedcells (I)
(I)
(I)
Mutation( )
Cancercell
Tumor
(delay)
![Page 42: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/42.jpg)
42
Dose-response for cell division rate
2.00E-04
3.00E-04
4.00E-04
5.00E-04
6.00E-04
7.00E-04
0 1 2 3 4 5 6 7
ppm formaldehyde
(Raw data)
2.0000E-04
2.5000E-04
3.0000E-04
3.5000E-04
4.0000E-04
4.5000E-04
5.0000E-04
5.5000E-04
0 1 2 3 4 5 6 7
ppm formaldehyde
(Hockey stick transformation)
![Page 43: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/43.jpg)
43
Simulation of tumor response in rats
![Page 44: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/44.jpg)
44
CIIT clonal growth cancer risk assessment for formaldehyde
(late ’90’s)
• Risk assessment goal– Combine effects of cytotoxicity and mutagenicity to
predict the tumor response
![Page 45: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/45.jpg)
45
1987 U.S. EPA
Tumor response
Inhaled ppm
Cancer model(LMS)
![Page 46: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/46.jpg)
46
1991 U.S. EPA
Inhaled ppm
Tissue dose(DPX)
Cancer model(LMS)
Tumor response
![Page 47: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/47.jpg)
47
1999 CIIT
Cell killing Cell proliferation
Mutagenicity(DPX)
Cancer model(Clonal growth)
Tumor response
Inhaled ppm
Tissue dose
CFD modeling
![Page 48: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/48.jpg)
48
Formaldehyde: Computational fluid dynamics models of the nasal airways
F344 RatRhesus Monkey
Human
![Page 49: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/49.jpg)
49
Human assessment
respiratory tracttumor data(control only)
cell replicationdose-response (rat)
site-specific flux intorespiratory tract epithelium
DPX dose-responseprediction (scale-upfrom rat and monkey)
mode of actiondose-responsesubmodels
cells at risk inrespiratory tract
single-path lungdosimetry model
cell replicationin control rats
human tumorincidence
CFD nasaldosimetry model
Inhaledformaldehyde
exposure scenario
2-STAGECLONALGROWTH MODEL
maximum likelihoodestimation of baselineparameter values
2-STAGECLONALGROWTHMODEL
![Page 50: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/50.jpg)
50
Baseline calibration against human lung cancer data
![Page 51: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/51.jpg)
51
DPX and direct mutation
• Direct mutation is assumed to be proportional to the amount of DPX:
• Is KMU big or small?
DPXKMUmutation ⋅=
![Page 52: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/52.jpg)
52
Grid search
![Page 53: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/53.jpg)
53
Optimal value of KMU is zero
![Page 54: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/54.jpg)
54
Upper bound on KMU
![Page 55: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/55.jpg)
55
Calculation of the value of KMU
• Grid search• Optimal value of KMU was zero
– Modeling implies that direct mutation is not a significant action of formaldehyde
• 95% upper confidence limit on KMU was estimated
![Page 56: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/56.jpg)
56
Human risk modeling
Normalcells (N)
Division
N)
Death/differentiation
(N)
Mutation(N )
Initiatedcells (I)
(I)
(I)
Mutation( )
Cancercell
Tumor
(delay)
![Page 57: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/57.jpg)
57
Final model: Hockey stick and 95% upper confidence limit on value of KMU
2.0000E-04
2.5000E-04
3.0000E-04
3.5000E-04
4.0000E-04
4.5000E-04
5.0000E-04
5.5000E-04
0 1 2 3 4 5 6 7
1 2 3 4 5 6 710
-4
10-3
10-2
10-1
PPM
DPX (pmol/mm
3)
DPX dose-response for Rhesus monkey
Vmax: 91.02. pmol/mm3/min
Km: 6.69 pmol/mm3 kf: 1.0878 1/min Tissue thickness ALWS: 0.5401 mm MT: 0.3120 mm NP: 0.2719 mm
95% UCL on KMU
![Page 58: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/58.jpg)
58
Predicted human cancer risks(hockey stick-shaped dose-response for cell
replication; optimal value for KMU)
2.0000E-04
2.5000E-04
3.0000E-04
3.5000E-04
4.0000E-04
4.5000E-04
5.0000E-04
5.5000E-04
0 1 2 3 4 5 6 71 2 3 4 5 6 7
10-4
10-3
10-2
10-1
PPM
DPX (pmol/mm
3)
DPX dose-response for Rhesus monkey
Vmax: 91.02. pmol/mm3/min
Km: 6.69 pmol/mm3 kf: 1.0878 1/min Tissue thickness ALWS: 0.5401 mm MT: 0.3120 mm NP: 0.2719 mm
Optimal value of KMUKMU = 0.
![Page 59: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/59.jpg)
59
“Negative risk” using raw dose-response for cell replication
2.00E-04
3.00E-04
4.00E-04
5.00E-04
6.00E-04
7.00E-04
0 1 2 3 4 5 6 7
1 2 3 4 5 6 710
-4
10-3
10-2
10-1
PPM
DPX (pmol/mm
3)
DPX dose-response for Rhesus monkey
Vmax: 91.02. pmol/mm3/min
Km: 6.69 pmol/mm3 kf: 1.0878 1/min Tissue thickness ALWS: 0.5401 mm MT: 0.3120 mm NP: 0.2719 mm
95% UCL on KMU
![Page 60: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/60.jpg)
60
Make conservative choices when faced with uncertainty
• Use hockey stick-shaped cell replication
• Use a 95% upper bound on the dose-response for the directly mutagenic mode of action– Statistically optimal model has 0 (zero) slope
• Risk model predicts low-dose linear risk.
• Optimal, data based model predicts negative risk at low doses
![Page 61: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/61.jpg)
61
Summary: CIIT Clonal Growth Assessment
• Either no additional risk or a much smaller level of risk than previous assessments
• Consistent with mechanistic database– Direct mutagenicity
– Cell replication
![Page 62: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/62.jpg)
62
Summary: CIIT Clonal Growth Assessment
• International acceptance– Health Canada– WHO– MAK Commission (Germany)– Australia– U.S. EPA (??)
• Peer-review
![Page 63: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/63.jpg)
63
IARC 2004
• Classified 1A based on nasopharyngeal cancer
• Myeloid leukemia data suggestive but not sufficient– Concern about mechanism
– British study negative
• Reclassification driven by epidemiology
• In my opinion inadequate consideration of regional dosimetry
![Page 64: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/64.jpg)
64
nasopharynx
Anteriornose
Wholenose
![Page 65: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/65.jpg)
65
IARC: hazard characterization vs. dose-response assessment
![Page 66: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/66.jpg)
66
Formaldehyde summary
• Nasal SCC in rats
• Mechanistic studies
• Risk Assessments
• Implications of the data
• IARC
![Page 67: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/67.jpg)
67
The future
![Page 68: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/68.jpg)
68
Outline
• Long-range goal
• Systems in biological organization
• Molecular pathways
• Data
• Example– Computational modeling
– Modularity
![Page 69: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/69.jpg)
69
Long-range goal
• A molecular-level understanding of dose- and time-response behaviors in laboratory animals and people.– Environmental risk assessment
– Drug development
– Public health
![Page 70: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/70.jpg)
70
Levels of biological organization
Populations
Organisms
Tissues
Cells
Organelles
Molecules(systems)
(systems)
(systems)
(systems)
(systems)
Descriptive Mechanistic
![Page 71: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/71.jpg)
71
Levels of biological organization
Populations
Organisms
Tissues
Cells
Organelles
Molecules(systems)
Today
![Page 72: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/72.jpg)
72
Molecular pathways
![Page 73: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/73.jpg)
73
Segment polarity genes in Drosophila
Albert & Othmer, J. Theor Biol. 223, 1 – 18, 2003
![Page 74: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/74.jpg)
74
ATM curatedPathway fromPathway Assist®
![Page 75: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/75.jpg)
75
Approach
• Initial pathway identification– Static map
• Existing data
• New data
• Computational modeling– Dynamic behavior
– Iterate with data collection
![Page 76: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/76.jpg)
76
Initial pathway identification
• Use commercial software that can integrate data from a variety of sources (Pathway Assist)– Scan Pub Med abstracts to identify “facts”
– Create pathway maps
– Incorporate other, unpublished data
• Quality control– Curate pathways
![Page 77: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/77.jpg)
77
Computational modeling
• To study the dynamic behavior of the pathway
• Analyze data– Are model predictions consistent with existing data?
• Make predictions– Suggest new experiments
– Ability to predict data before it is collected is a good test of the model
![Page 78: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/78.jpg)
78
DNA damage and cell cycle checkpoints
(a) G1/S Checkpoint (b) G2/M Checkpoint (a) G1/S Checkpoint (b) G2/M Checkpoint
![Page 79: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/79.jpg)
79
p21 time-course data and simulation
Experimental data
![Page 80: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/80.jpg)
80
IR
Mu
tatio
n F
ract
ion
Ra
te
model calculated values
(Redpath et al, 2001)
Mutations dose-response and model prediction
![Page 81: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/81.jpg)
81
Data
![Page 82: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/82.jpg)
82
(Fat)
Liver
Rest of Body
Air-bloodinterface
Venousblood
Tissue dosimetry is the “front end” to a molecular pathway model
![Page 83: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/83.jpg)
83
Gain-of-function and loss-of-function screens to study network structure
• Selectively alter behavior of the network– Loss-of-function
• SiRNA
– Gain-of-function
• full-length genes
• Look for concordance between lab studies and the behavior of the computational model– Mimic gain-of-function and loss-of-function changes in
the computer
![Page 84: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/84.jpg)
84
Example
• Skin irritation
• MAPK, IL-1, and NF-B computational “modules”
• High throughput overexpression data to characterize IL-1 – MAPK interaction with respect to NF-B
![Page 85: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/85.jpg)
85
Skin Irritation
Epidermis
Dermis
Dead cells
Blood vessels
(keratinocytes)
Nerve Ending
s(fibroblasts)
Chemical
Tissue damage
Tissue damage
A cascade of inflammatory responses
(cytokines)
• Study on the dose response of the skin cells to inflammatory cytokines contributes to quantitative assessment of skin irritation
![Page 86: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/86.jpg)
86
Modular Composition of IL-1 Signaling
IL-1R
IL-1
Secondary messenger
NF-B MAPK Others
Extracellular
Intracellular
IL-6, etc.Transcriptional factors
IL-1 specific top module
Constitutive downstream NF-B module
![Page 87: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/87.jpg)
87
IL-1
IL-1R
MyD88
P
IRAK
Degraded
IRAK gene
IRAK
IRA
K
P
TRAF6
TAB2
IRA
K
P
TRAF6
TA
K1
TA
B1
P
IK PIK
Nucleus
Cytoplasm
Top IL-1 Signaling Module
NF-kB moduleSelf-limiting mechanism
![Page 88: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/88.jpg)
88
Top Module Simulation
• IL-1 receptor number and ligand binding parameters from human keratinocytes
• Other parameters constrained by reasonable ranges of similar reactions/molecules, and tuned to fit data
Time (hrs) Time (hrs)
TA
K1
*
IRA
Kp
Increasing IRAKp
degradation
![Page 89: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/89.jpg)
89
IK P
NFBIB
P
NFB
IB Degraded
IB geneNFB
IB
IL-6 geneNFB NFB
IB
PNFBIB
Nucleus
Cytoplasm
Constitutive NF-B Signaling Module
IK
Negativefeedback
Input signal
![Page 90: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/90.jpg)
90
NF-B Module Simulation
• Parameters from existing NF-B model (Hoffmann et al., 2002) and refined to fit experimental data in literature
Time (hrs)
Con
cen
trat i
on
(M
) IB
NF-B+ _
Time (hrs)
Con
cen
trat i
on
(M
)
IL-6
Add constant
input signal
Longer delay
Smoothened oscillations
![Page 91: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/91.jpg)
91
The IB–NF-B Signaling Module: Temporal Control and Selective Gene ActivationAlexander Hoffmann, Andre Levchenko, Martin L. Scott, David Baltimore
Science 298:1241 – 1245, 2002
6 hr
![Page 92: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/92.jpg)
92
MAPK intracellular signaling cascades
http://www.weizmann.ac.il/Biology/open_day/book/rony_seger.pdf
![Page 93: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/93.jpg)
93
Growth factor
MAPKKK
MAPKK
MAPKPLA2
AA
PKC
PLA2
AA
PKC
MKPMKP
![Page 94: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/94.jpg)
94
MAPK time-course and bifurcation after a short pulse of PDGF
Input pulse
Growth factor
MAPKKK
MAPKK
MAPKPLA2
AA
PKC
PLA2
AA
PKC
MKPMKP
![Page 95: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/95.jpg)
95
PIRAK
DegradedIRAK gene
TRAF6
TAB2 TAK1TAB1
I
?
K
IL-1
IL-1R
MyD88
P
IRAK
P
IRAKIRAK
I
?
KP
P
NF
?
B module
NF
?
B-dependenttranscription
MAP3K1
IL-1 MAPK crosstalk and NFkB activation
![Page 96: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/96.jpg)
96
Gain-of-function screen
![Page 97: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/97.jpg)
97
Model prediction
![Page 98: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/98.jpg)
98
Future directions
• Computational modeling and data collection at higher levels of biological organization– Cells
• Intercellular communication
– Tissues
– Organisms
• NIH initiatives
• Environmental health risk, drugs ==> in vivo
![Page 99: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/99.jpg)
99
Summary
• Biological organization and systems
• Molecular pathways– identification
– Computational modeling
• Data– Gain-of-function
– Loss-of-function
• Skin irritation example– 3 modules
– Crosstalk
– Targeted data collection
![Page 100: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/100.jpg)
100
Acknowledgements
• Colleagues who worked on the clonal growth risk assessment– Fred Miller, Julian Preston, Paul Schlosser, Julie
Kimbell, Betsy Gross, Suresh Moolgavkar, Georg Luebeck, Derek Janszen, Mercedes Casanova, Henry Heck, John Overton, Steve Seilkop
![Page 101: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/101.jpg)
101
Acknowledgements
• CIIT Centers for Health Research– Rusty Thomas
– Maggie Zhao
– Qiang Zhang
– Mel Andersen
• Purdue– Yanan Zheng
• Wright State University– Jim McDougal
• Funding– DOE
– ACC
![Page 102: 1 Dose-Response Modeling: Past, Present, and Future Rory B. Conolly, Sc.D. Center for Computational Systems Biology & Human Health Assessment CIIT Centers.](https://reader034.fdocuments.in/reader034/viewer/2022051517/56649eef5503460f94bffd68/html5/thumbnails/102.jpg)
102
End